Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$59,473,932
-$4,602,591 QoQ
Shares Held
234,177
-10.7% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
1.22%
of 13F equity value
Holder Rank
#406
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Clearstead Advisors, LLC holds $207,269,806 across 16 Drug Manufacturers - General names. JNJ ranks #2 (28.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
55,467 | $66,528,789 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
234,177 | $59,473,932 | |
| 3 | ABBV |
AbbVie Inc.
|
111,021 | $27,937,324 | |
| 4 | AMGN |
Amgen Inc
|
40,211 | $14,561,207 | |
| 5 | MRK |
Merck & Co., Inc.
|
112,376 | $14,440,316 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
128,389 | $7,397,774 | |
| 7 | PFE |
Pfizer Inc
|
197,145 | $4,747,251 | |
| 8 | NVS |
Novartis AG
|
25,239 | $3,955,456 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $59,473,932 | 234,177 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $64,076,523 | 262,136 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $48,738,794 | 235,510 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $43,781,370 | 236,120 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $36,451,954 | 238,638 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $39,992,150 | 241,149 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $32,668,356 | 225,891 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $38,653,578 | 238,514 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $34,955,771 | 239,161 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $12,907,513 | 81,595 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $13,110,517 | 83,645 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $15,108,684 | 97,006 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $13,349,022 | 80,649 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $9,550,635 | 61,617 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $10,632,563 | 60,190 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $9,675,486 | 59,228 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $12,326,471 | 69,441 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $12,017,611 | 67,808 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $11,222,363 | 65,601 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $10,141,231 | 62,794 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $10,459,507 | 63,491 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $9,878,914 | 60,109 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $9,016,929 | 57,294 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $7,165,892 | 48,132 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $6,874,416 | 48,883 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $6,298,960 | 48,036 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||